Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance upgrade on Thursday 4th of May 2017 from 8.00am to 9.00am (BST).

During this time our websites will be offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 8, 2013
Previous Article Next Article

Synthesis and evaluation of novel ellipticines as potential anti-cancer agents

Author affiliations

Abstract

Drugs that inhibit DNA topoisomerase I and DNA topoisomerase II have been widely used in cancer chemotherapy. We report herein the results of a focused medicinal chemistry effort around novel ellipticinium salts which target topoisomerase I and II enzymes with improved solubility. The salts were prepared by reaction of ellipticine with the required alkyl halide and evaluated for DNA intercalation, topoisomerase inhibition and growth inhibition against 12 cancer cell lines. Results from the topoisomerase I relaxation assay indicated that all novel ellipticine derivatives behaved as intercalating agents. At a concentration of 100 μM, specific topoisomerase I inhibition was not observed. Two of the derivatives under investigation were found to fully inhibit the DNA decatenation reaction at a concentration of 100 μM, indicative of topoisomerase II inhibition. N-Alkylation of ellipticine was found to enhance the observed growth inhibition across all cell lines and induce growth inhibition comparable to that of Irinotecan (CPT-11; GI50 1–18 μM) and in some cell lines better than Etoposide (VP-16; GI50 = 0.04–5.2 μM). 6-Methylellipticine was the most potent growth inhibitory compound assessed (GI50 = 0.47–0.9 μM). N-Alkylation of 6-methylellipticine was found to reduce this response with GI50 values in the range of 1.3–28 μM.

Graphical abstract: Synthesis and evaluation of novel ellipticines as potential anti-cancer agents

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 09 Nov 2012, accepted on 03 Jan 2013 and first published on 03 Jan 2013


Article type: Paper
DOI: 10.1039/C2OB27186A
Citation: Org. Biomol. Chem., 2013,11, 1334-1344
  •   Request permissions

    Synthesis and evaluation of novel ellipticines as potential anti-cancer agents

    F. M. Deane, E. C. O'Sullivan, A. R. Maguire, J. Gilbert, J. A. Sakoff, A. McCluskey and F. O. McCarthy, Org. Biomol. Chem., 2013, 11, 1334
    DOI: 10.1039/C2OB27186A

Search articles by author